State of Wyoming’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

State of Wyoming’s Portfolio SEEL Stock Details SEEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10	Closed	-$7.37K	–	1855
2023 Q3	$7.37K	Buy	10 +1	+11%	+$4.29K	﹤0.01%	1538
2023 Q2	$39.9K	Buy	+9	New	+$31.2K	0.01%	1211
2022 Q4	–	Sell	-8	Closed	-$30K	–	1795
2022 Q3	$30K	Buy	+8	New	+$31.5K	0.01%	1187

Other funds holding SEEL

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Wealth Effects Boston, Massachusetts $370M AUM 97.79% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GJL

Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return

MWM

Modera Wealth Management Westwood, New Jersey $9.37B AUM 23.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State of Wyoming's SEEL Position: Q4 2023 in Review

State of Wyoming sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q4 2023, closing a stake of 10 shares — an estimated $7.37K sold.

State of Wyoming first reported a position in SEEL in Q3 2022 and held it in 3 quarters. The position peaked at $39.9K in Q2 2023. 32 funds tracked by Wall St. Rank hold SEEL as of Q4 2023.

State of Wyoming reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
State of Wyoming sold 10 Seelos Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $7.37K.
State of Wyoming first reported a position in Seelos Therapeutics, Inc. Common Stock in Q3 2022 and held it in 3 quarters.
State of Wyoming's Seelos Therapeutics, Inc. Common Stock position peaked at $39.9K in Q2 2023.
32 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q4 2023.

Based on State of Wyoming's 13F filing for Q4 2023, filed 15 Feb 2024.